Filing Flows › Astrana Health (ASTH) › Q3 2026
Astrana Health (ASTH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Astrana Health (ASTH) reported revenue of $1.0B for the third quarter 2026 (Q3 2026), +7% from a year earlier and +5% from the quarter before. Operating margin was 3.9%, net earnings $13.0M (1.3% of revenue).
Astrana Health, Q3 2026: revenue $1.0B (+7% year over year), operating margin 3.9%, net earnings $13.0M, operating cash flow $16.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0B | +5% | +7% |
| Operating profit | $39.9M | +16% | +108% |
| Net earnings | $13.0M | -34% | 35× |
| Operating cash flow | $16.3M | -50% | +63% |
| Free cash flow | $12.4M | -57% | +68% |
What changed
Revenue was $1.0B in Q3 2026, up 7% year over year and up 5% from the previous quarter. Health Care Capitation Revenue was the largest line at 92% of revenue. Health Care Capitation Revenue added $0.07B year over year (up 8%), 108% of the total change. Health Care Other declined 21%.
Operating profit was $0.04B, a 3.9% margin (up 1.9 points year over year). Of the extra revenue versus Q3 2025, 31% reached operating profit, above the 2% margin then. Total costs grew 5% against revenue growth of 7%. Net earnings were $0.01B, up 3372% year over year. The effective tax rate was 37.1%.
Operating cash flow was $0.02B (up 63% year over year), 80% of net income including minority interests. Non-cash charges added back $0.02B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.04B. Capital expenditures of $3.8M left free cash flow of $0.01B.
Questions
What was Astrana Health's revenue in the third quarter 2026?
Astrana Health (ASTH) reported revenue of $1.0B for the third quarter 2026 (Q3 2026), +7% from a year earlier and +5% from the quarter before.
Was Astrana Health profitable in the third quarter 2026?
Operating profit was $39.9M (3.9% of revenue) and net earnings $13.0M.
Source: Astrana Health 10-Q on SEC EDGAR.